TWD
STOK icon

True Wealth Design’s Stoke Therapeutics STOK Stock Holding History

True Wealth Design’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131 Hold
4
– – ﹤0.01% 2513
2026
Q1 		$131 Hold
4
– – ﹤0.01% 2420
2025
Q4 		$127 Hold
4
– – ﹤0.01% 2299
2025
Q3 		$94 Hold
4
– – ﹤0.01% 2456
2025
Q2 		$46 Buy
+4
New +$38 ﹤0.01% 2398
2024
Q4 		– Sell
-139
Closed -$1.71K – 1508
2024
Q3 		$1.71K Buy
+139
New +$1.97K ﹤0.01% 834

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design's STOK Position: Q2 2026 in Review

True Wealth Design held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 4 shares worth $131. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

True Wealth Design first reported a position in STOK in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.71K in Q3 2024. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • True Wealth Design held 4 shares of Stoke Therapeutics worth $131 as of Q2 2026.
  • True Wealth Design left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2513 holding.
  • True Wealth Design first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • True Wealth Design's Stoke Therapeutics position peaked at $1.71K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.